ArticleExperimental and therapeutic medicine2026
Drug-related problems in pediatric patients with chronic kidney disease: A single-center prospective study.
Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Currently, there is a lack of data on drug-related problems (DRPs) in pediatric patients with chronic kidney disease (CKD) in China. The aim of the present study was to determine the incidence and determinants of DRPs in pediatric patients with CKD and to inform evidence-based pharmacotherapy for this population. For this purpose, a single-center prospective study was conducted at the Guiyang Maternal and Child Health Care Hospital (Guiyang, China) between January and December 2023. The Pharmaceutical Care Network Europe (PCNE) taxonomy [version 9.1 (v9.1)] was adapted to reflect the unique characteristics of pediatric patients with CKD; all identified DRPs were classified according to the modified PCNE v9.1 and were subsequently analyzed. The results demonstrated that among the 383 hospitalized children with CKD, 136 patients (35.51%) experienced 203 DRPs; the majority of problems pertained to treatment effectiveness (190; 93.60%) and of the 223 underlying causes identified, 79 (35.43%) were related to drug selection. Clinical pharmacists initiated 254 interventions; 243 (95.67%) were fully accepted and implemented. In conclusion, the present study demonstrated that DRPs are common in pediatric patients with CKD. The implementation of a pharmacist-led medication reconciliation model, supported by an adapted PCNE tool, was associated with a high intervention acceptance rate. However, the present study was conducted in a single center and the findings obtained need to be validated in other centers, thereby providing more valuable references for the identification and management of DRPs in children with CKD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.